Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC Injections for Severe Pelvic Radiation Disease (PRISME)
NCT02814864Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2021
- Primary completion
- Apr 2022
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of Provacel in Pelvic Radiation Disease (PRD), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
Provacel
03
Conditions
Pelvic Radiation Disease (PRD)
Beyond the preview
Go deeper on NCT02814864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02814864.